Argitalpenak (61) IGNACIO ANTEPARA ERCORECA argitalpenak

2021

  1. Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy

    European Annals of Allergy and Clinical Immunology, Vol. 53, Núm. 2, pp. 67-74

  2. Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

2015

  1. Epidemiology of asthma exacerbations and their relation with environmental factors in the Basque Country

    Clinical and Experimental Allergy, Vol. 45, Núm. 6, pp. 1099-1108

  2. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema

    Annals of Allergy, Asthma and Immunology, Vol. 114, Núm. 5, pp. 418-419.e1

2014

  1. Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus

    Clinical and Translational Allergy, Vol. 4, Núm. 1

2013

  1. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

2012

  1. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria

    Expert Review of Clinical Immunology, Vol. 8, Núm. 1, pp. 33-41

  2. Diagnostic utility of components in allergy to Anisakis simplex

    Journal of Investigational Allergology and Clinical Immunology, Vol. 22, Núm. 1, pp. 13-19

  3. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

  4. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification

    Rhinology, Vol. 50, Núm. 1, pp. 33-36

2011

  1. Recomendaciones y algoritmos de práctica clínica de la Sociedad Española de Alergología e Inmunología Clínica.

    Equalmas 5

  2. Two patients with anaphylactic shock due to fosfomycin

    Annals of Allergy, Asthma and Immunology

2010

  1. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: A multi-centre, double-blind, randomized, placebo-controlled study

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 65, Núm. 4, pp. 516-528

  2. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 65, Núm. 12, pp. 1609-1613

  3. Recomendaciones y algoritmos de práctica clínica de la Sociedad Española de Alergología e Inmunología Clínica.

    Equalmas 5

  4. Recomendaciones y algoritmos de práctica clínica de la Sociedad Española de Alergología e Inmunología Clínica.

    Equalmas 5

  5. Recomendaciones y algoritmos de práctica clínica de la Sociedad Española de Alergología e Inmunología Clínica.

    Equalmas 5

2009

  1. Allergenicity and cross-reactivity of pine pollen

    Clinical and Experimental Allergy, Vol. 39, Núm. 9, pp. 1438-1446

  2. Component-resolved diagnosis of pollen allergy based on skin testing with profilin, polcalcin and lipid transfer protein pan-allergens

    Clinical and Experimental Allergy, Vol. 39, Núm. 11, pp. 1764-1773

  3. Component-resolved in vitro diagnosis in peach-allergic patients

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. 1, pp. 13-20